Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma.
Medikonda R, Choi J, Pant A, Saleh L, Routkevitch D, Tong L, Belcaid Z, Kim YH, Jackson CM, Jackson C, Mathios D, Xia Y, Shah PP, Patel K, Kim T, Srivastava S, Huq S, Ehresman J, Pennington Z, Tyler B, Brem H, Lim M.
Medikonda R, et al. Among authors: pant a.
J Neurosurg. 2021 Aug 13;136(2):379-388. doi: 10.3171/2021.1.JNS202482. Print 2022 Feb 1.
J Neurosurg. 2021.
PMID: 34388730